Expression Level of NRP1 and SMAD2 in Correlation to Mutational Status of Ras (BRAF) in Pancreatic Cancer

HPB - United Kingdom
doi 10.1016/j.hpb.2019.03.241
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Mutational Analysis of the BRAF, RAS and EGFR Genes in Human Adrenocortical Carcinomas

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2009English

RAS and BRAF in Metastatic Colorectal Cancer Management

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2016English

Extended RAS Analysis and Correlation With Overall Survival in Advanced Pancreatic Cancer

British Journal of Cancer
Cancer ResearchOncology
2017English

BRAF -V600 Mutational Status Affects Recurrence Patterns of Melanoma Brain Metastasis

International Journal of Cancer
Cancer ResearchOncology
2017English

Impact of Tumour RAS/BRAF Status in a First-Line Study of Panitumumab + FOLFIRI in Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2016English

Merkel Cell Carcinoma: Correlation of KIT Expression With Survival and Evaluation of KIT Gene Mutational Status

Human Pathology
Forensic MedicinePathology
2010English

Mutational Activation of BRAF Confers Sensitivity to Transforming Growth Factor Beta Inhibitors in Human Cancer Cells

Oncotarget
Oncology
2016English

OA12.06 Mutational Landscape of BRAF V600E Positive Lung Cancer Patients Following BRAF Directed Therapy Failure

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Correlation of Tumor Size and Survival in Pancreatic Cancer

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy